2CARE HEALTHCARE SOLUTIONS
Q4 2024 Financial Report & Performance Summary

Reporting Period: October 1, 2024 - December 31, 2024
Report Date: January 15, 2025

EXECUTIVE SUMMARY:
Q4 2024 was a record quarter for 2Care, with strong revenue growth across all product lines and successful expansion into two new markets. Annual recurring revenue (ARR) grew 34% year-over-year.

FINANCIAL HIGHLIGHTS - Q4 2024:

Total Revenue: $12.3 million (↑ 28% YoY, ↑ 15% QoQ)
- SaaS Subscription Revenue: $9.8 million (80% of total)
- Professional Services: $1.8 million (15% of total)
- Marketplace & Integration Revenue: $0.7 million (5% of total)

Annual Recurring Revenue (ARR): $38.5 million (↑ 34% YoY)

Gross Margin: 72% (up from 68% in Q3 2024)
Operating Margin: 12% (first profitable quarter)
Net Income: $1.47 million (vs. loss of $0.8M in Q4 2023)

CUSTOMER METRICS:
Total Customers: 2,347 (↑ 18% YoY)
- Enterprise (1000+ beds): 47 customers
- Mid-Market (100-1000 beds): 384 customers  
- Small Clinics (<100 beds): 1,916 customers

New Customer Acquisitions (Q4): 127 facilities
Customer Churn Rate: 1.5% (industry avg: 3-5%)
Net Revenue Retention: 118%
Average Contract Value (ACV): $16,400

GEOGRAPHIC BREAKDOWN:
India: $8.1M (66% of revenue)
Singapore: $2.3M (19% of revenue)
Malaysia: $1.1M (9% of revenue)
Thailand: $0.5M (4% of revenue)
Indonesia: $0.3M (2% of revenue)

PRODUCT PERFORMANCE:
2Care Cloud EHR: $6.2M revenue, 1,847 active installations
2Care Telehealth: $2.8M revenue, 340% growth YoY (COVID tailwind continuing)
2Care Analytics: $1.9M revenue, 89 enterprise customers
2Care Pharmacy: $0.9M revenue, 456 pharmacy integrations
2Care Billing: $0.5M revenue, 234 customers

KEY WINS IN Q4:
- Secured largest customer: Max Healthcare (42 hospitals, $2.1M ARR)
- Partnership with Singapore General Hospital for AI diagnostics pilot
- Launched 2Care Labs integration with top 3 diagnostic chains in India
- Expanded sales team by 40% to support 2025 growth targets

EXPENSES BREAKDOWN:
R&D Investment: $3.2M (26% of revenue) - AI/ML capabilities expansion
Sales & Marketing: $4.1M (33% of revenue) - Enterprise sales team growth
General & Administrative: $2.8M (23% of revenue)
Customer Success: $1.2M (10% of revenue)

CASH POSITION:
Cash & Equivalents: $18.7 million
Burn Rate: Profitable (positive operating cash flow of $1.2M in Q4)
Runway: N/A (cash flow positive)

2025 OUTLOOK:
Revenue Target: $58-62 million (50% growth)
Path to EBITDA positive for full year 2025
Plans to expand to Philippines and Vietnam
Investment focus: AI diagnostics, interoperability, mobile patient app

RISKS & CHALLENGES:
- Increasing competition from international players entering Asian market
- Regulatory compliance costs in new markets
- Healthcare provider budget constraints in some regions
- Talent acquisition and retention in competitive tech market